Will upadatinib develop wildly after discontinuation? Is there a risk of recurrence or worsening of symptoms after discontinuing medication?

Upadacitinib, a Janus kinase (JAK) inhibitor, is mainly used to treat immune-mediated diseases such as rheumatoid arthritis. For some patients, long-term use of the drug can significantly control the disease and reduce symptoms, especially symptoms of arthritis and reduce inflammation. However, regarding the risks after discontinuation of medication, particularly whether symptoms worsen rapidly, current research suggests that there is a real possibility of relapse or worsening of symptoms after discontinuation of medication.

The risk of relapse after discontinuation is related to the continuation of treatment. Because upadatinib relieves symptoms by suppressing overactivity of the immune system, stopping the drug may cause the immune system to reactivate, triggering a relapse. For diseases such as rheumatoid arthritis, symptoms may gradually return within weeks to months after stopping the drug, and symptoms such as joint pain and swelling may return. Therefore, patients need to strictly follow the doctor's recommendations to gradually reduce the medication when stopping the medication, and regularly monitor changes in condition after stopping the medication.

Although the effects of upadatinib are usually dramatic, once the drug is discontinued, a patient's immune system may rapidly resume its function, leading to a return of symptoms. Studies have shown that in the early stages after drug withdrawal, patients' immune responses are more sensitive, which may quickly lead to an exacerbation of the disease. This phenomenon is common with many immunosuppressive therapies, especially if appropriate dose reduction measures are not taken. Therefore, during the withdrawal process, doctors usually recommend that patients continue other alternative treatments or maintain low-dose medication to prevent the condition from worsening sharply.

Not every patient will experience worsening of symptoms after stopping medication. Depending on the patient's condition and response, different reactions may occur after stopping the drug. Some patients may experience a mild recurrence of symptoms upon discontinuation of the drug, while others may experience no significant worsening of symptoms. Therefore, when deciding whether to discontinue a medication, doctors will make decisions based on the patient's overall health, medical history, and drug response to help reduce the risk of relapse.

Reference materials:https://www.rinvoq.com/